Gamalate B6 solution oral

מדינה: ארמניה

שפה: אנגלית

מקור: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

מרכיב פעיל:

magnesium glutamate hydrobromide, gamma-aminobutyric acid, gamma-amino-beta-hydroxybutyric acid, vitamin B6

זמין מ:

Ferrer International

קוד ATC:

առկա չէ (N06BX)

INN (שם בינלאומי):

magnesium glutamate hydrobromide, gamma-aminobutyric acid, gamma-amino-beta-hydroxybutyric acid, vitamin B6

כמות:

20mg/ml+ 20mg/ml+ 10mg/ml+ 10mg/ml

טופס פרצבטיות:

solution oral

יחידות באריזה:

80ml glass bottle

סוג מרשם:

Prescription

מצב אישור:

Registered

תאריך אישור:

2020-10-21

מאפייני מוצר

1.
NAME OF THE MEDICINAL PRODUCT
Gamalate B
6
oral solution
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 100 ml of oral solution contains:
- magnesium glutamate hydrobromide (MGH) ........................... 2
g
- -amino-butyric acid (GABA)
...................................................... 2 g
- -amino β-hydroxybutyric acid (GABOB)
................................... 1 g
- Pyridoxine hydrochloride
........................................................... 1 g
Excipient(s) with known effect
Sorbitol
70%
(E-420);
Sunset
Yellow
FCF
(E-110);
methyl
para-hydroxybenzoate
(E-218);
Sodium propyl parahydroxybenzoate (E-216).
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORMULATION
Oral solution
4.
CLINICAL PARTICULARS
4.1
Therapeutic indications
Gamalate B
6
belongs to the group of drugs called psychostimulants and nootropics.
Gamalate B
6
owing to the action of its active components: cerebrotonic aminoacids
(GABA and
GABOB), mild sedative (MGH) and vitamin B
6
, exerts a cerebral energizing and neuroregulating
action. The aminoacids and vitamin B
6
take part in the cerebral metabolism and increase the
energetic potential of the nervous cell. It improves the output of the
intellectual qualities.
Indications
Adults:
Adjuvant in functional asthenias:
-
Emotional instability.
-
Concentration and memory difficulty.
-
Depression and nervous breakdown.
-
Decreased adaptation capacity.
Children:
-
Concentration difficulty and decreased school output.
-
Lack of adaptation to social, family and school milieu.
4.2
Dosage and method of administration
Posology
Adults and children over 7 years: 10 ml 2 or 3 times a day (every 12
or 8 hours).
Children up to 2 years: 2.5 ml 3 times a day (every 8 hours).
From 2-4 years: 5 ml 3 times a day (every 8 hours).
From 4-7 years: 10 ml 2 times a day (every 12 hours).
These dose recommendations may be modified by the doctor.
Method of administration
This medicinal product is administered by oral route. May be
administered before or after
main meals.
4.3
Con